Manali A. Shendrikar, MD, MPH Is the Latest Physician from Saint John's Physician Partners to Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians
ROCKVILLE CENTRE, N.Y., July 22, 2025 /PRNewswire/ — Concierge Choice Physicians (CCP), the nation's leading full-service concierge medical service provider, announces today that Manali A. Shendrikar, MD, MPH, from Santa Monica Family Physicians, is the newest doctor in Saint John's Physician Partners (SJPP), part of Providence, to now offer CCP's Hybrid Choice™ program. This enhanced practice experience provides patients with greater connectivity and support from their chosen doctor.
Unlike conventional concierge programs, CCP's Hybrid Choice program is a unique style of membership medicine that works well in large healthcare organizations like SJPP. It allows physicians to provide the highest level of service to just those patients who want it, while continuing to see and care for all of the patients in their network. Patients are able to choose the practice experience they want. No patients are ever turned away, and the physicians continue to accept insurance and Medicare. The program is also being used to improve physician satisfaction and support medical practices with much-needed additional revenue. A portion of the revenue generated from membership fees supports St. John's charitable mission to serve all, especially the most poor and vulnerable.
'I want to be the go-to doctor for my patients—but that's not something that can be promised in such a demanding healthcare marketplace,' says Dr. Shendrikar. 'This program allows patients to secure that kind of connectivity. It's a great option for many patients who feel they would benefit from the peace of mind that comes from knowing they will always see me at appointments. I'm looking forward to practicing in this more personalized style.'
Patients who enroll in Dr. Shendrikar's Hybrid Choice program pay an annual fee that allows her to provide services that go beyond what is typically offered in a traditional practice, including: more time together; a greater focus on wellness with a comprehensive annual exam and specialty lab work; relaxed, easy-to-secure appointments that generally start on time; convenient and direct ways to communicate with Dr. Shendrikar both at the office and after hours; enhanced medical advocacy; and coordination with other healthcare professionals.
Dr. Manali A. Shendrikar practices at Santa Monica Family Physicians, 2021 Santa Monica Blvd., Suite 625E, Santa Monica, CA 90404. Her Hybrid Choice program is available for an annual membership fee. For more information on the program or to join, contact Concierge Choice Physicians at (877) 888-5590 or email members@ccpmd.com.
About Manali A. Shendrikar, MD, MPHDr. Shendrikar is an experienced, board-certified family medicine physician. She graduated medical school at the University of Texas, Health Science Center at San Antonio, TX and completed her residency at Santa Monica-UCLA Medical Center, in Santa Monica, CA.
About Concierge Choice Physicians (CCP)Dedicated to providing real options for patients and physicians, Concierge Choice Physicians™ is the largest private provider of the full range of concierge programs available today—Hybrid and FullFlex™. The company provides innovative, flexible and affordable models proven to work in medical practices of any size—from solo physicians to large medical practice corporations—both independent and affiliated with hospitals or health systems. Headquartered in Rockville Centre, NY, the company has worked with thousands of physicians in 35 states. For more information, please visit www.ccpmd.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
5 days ago
- Malaysian Reserve
Manali A. Shendrikar, MD, MPH Is the Latest Physician from Saint John's Physician Partners to Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians
Leading not-for-profit healthcare organization in greater Los Angeles allows patients to choose a closer doctor-patient relationship ROCKVILLE CENTRE, N.Y., July 22, 2025 /PRNewswire/ — Concierge Choice Physicians (CCP), the nation's leading full-service concierge medical service provider, announces today that Manali A. Shendrikar, MD, MPH, from Santa Monica Family Physicians, is the newest doctor in Saint John's Physician Partners (SJPP), part of Providence, to now offer CCP's Hybrid Choice™ program. This enhanced practice experience provides patients with greater connectivity and support from their chosen doctor. Unlike conventional concierge programs, CCP's Hybrid Choice program is a unique style of membership medicine that works well in large healthcare organizations like SJPP. It allows physicians to provide the highest level of service to just those patients who want it, while continuing to see and care for all of the patients in their network. Patients are able to choose the practice experience they want. No patients are ever turned away, and the physicians continue to accept insurance and Medicare. The program is also being used to improve physician satisfaction and support medical practices with much-needed additional revenue. A portion of the revenue generated from membership fees supports St. John's charitable mission to serve all, especially the most poor and vulnerable. 'I want to be the go-to doctor for my patients—but that's not something that can be promised in such a demanding healthcare marketplace,' says Dr. Shendrikar. 'This program allows patients to secure that kind of connectivity. It's a great option for many patients who feel they would benefit from the peace of mind that comes from knowing they will always see me at appointments. I'm looking forward to practicing in this more personalized style.' Patients who enroll in Dr. Shendrikar's Hybrid Choice program pay an annual fee that allows her to provide services that go beyond what is typically offered in a traditional practice, including: more time together; a greater focus on wellness with a comprehensive annual exam and specialty lab work; relaxed, easy-to-secure appointments that generally start on time; convenient and direct ways to communicate with Dr. Shendrikar both at the office and after hours; enhanced medical advocacy; and coordination with other healthcare professionals. Dr. Manali A. Shendrikar practices at Santa Monica Family Physicians, 2021 Santa Monica Blvd., Suite 625E, Santa Monica, CA 90404. Her Hybrid Choice program is available for an annual membership fee. For more information on the program or to join, contact Concierge Choice Physicians at (877) 888-5590 or email members@ About Manali A. Shendrikar, MD, MPHDr. Shendrikar is an experienced, board-certified family medicine physician. She graduated medical school at the University of Texas, Health Science Center at San Antonio, TX and completed her residency at Santa Monica-UCLA Medical Center, in Santa Monica, CA. About Concierge Choice Physicians (CCP)Dedicated to providing real options for patients and physicians, Concierge Choice Physicians™ is the largest private provider of the full range of concierge programs available today—Hybrid and FullFlex™. The company provides innovative, flexible and affordable models proven to work in medical practices of any size—from solo physicians to large medical practice corporations—both independent and affiliated with hospitals or health systems. Headquartered in Rockville Centre, NY, the company has worked with thousands of physicians in 35 states. For more information, please visit
Malaysian Reserve
16-07-2025
- Malaysian Reserve
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test
Virtual public CAC meeting to be held September 4, 2025, at 2:00 p.m. ET NEW YORK, July 16, 2025 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) ('Lucid' or the 'Company'), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that on Thursday, September 4, 2025, from 2:00 to 4:00 p.m. ET, MolDX-participating Medicare Administrative Contractors (MACs)—Palmetto GBA, CGS Administrators, Noridian Healthcare Solutions, and WPS Government Health Administrators—will convene a MolDX Contractor Advisory Committee (CAC) Meeting of medical experts as a critical step in the reconsideration of Local Coverage Determination (LCD) L39256, 'MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, Neoplasia,' as requested by Lucid in November 2024 to secure Medicare coverage for its EsoGuard® Esophageal DNA Test. 'We are grateful to the MolDX team for their rigorous evaluation of our clinical evidence package, which has culminated in this CAC meeting where medical experts will contribute deep domain expertise and real-world experience in nonendoscopic esophageal precancer testing,' said Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer. 'We view this meeting as strong evidence of progress toward a positive Medicare coverage policy outcome. There is broad consensus within the GI community on the clinical utility of EsoGuard for esophageal precancer testing, supported by professional society guidelines, peer-reviewed publications, and real-world experience from nearly 40,000 patients referred for EsoGuard testing to date. With our strengthened balance sheet, we are well equipped to successfully navigate the final stages of this process.' The CAC panel will discuss the clinical literature related to Local Coverage Determination (LCD) L39256, and medical experts will have the opportunity to provide important clinical context for the evidence. Discussions will occur between CAC panelists and Contractor Medical Directors. The public may attend; however, questions from the public will not be entertained. Interested stakeholders may register to listen to the CAC meeting via Microsoft Teams Webinar. Advance registration is required and must be completed by Wednesday, September 3, 2025, at 11:59 p.m. ET. To register, please visit: Register Here. About Lucid DiagnosticsLucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients. For more information about Lucid, please visit and for more information about its parent company PAVmed, please visit Forward-Looking StatementsThis press release includes forward-looking statements that involve risk and uncertainties. Forward-looking statements are any statements that are not historical facts. Such forward-looking statements, which are based upon the current beliefs and expectations of Lucid's management, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Risks and uncertainties that may cause such differences include, among other things, volatility in the price of Lucid's common stock; general economic and market conditions; the uncertainties inherent in research and development, including the cost and time required to advance Lucid's products to regulatory submission; whether regulatory authorities will be satisfied with the design of and results from Lucid's clinical and preclinical studies; whether and when Lucid's products are cleared by regulatory authorities; market acceptance of Lucid's products once cleared and commercialized; Lucid's ability to raise additional funding as needed; and other competitive developments. In addition, Lucid continues to monitor the COVID-19 pandemic and the pandemic's impact on Lucid's businesses. These factors are difficult or impossible to predict accurately and many of them are beyond Lucid's control. In addition, new risks and uncertainties may arise from time to time and are difficult to predict. For a further list and description of these and other important risks and uncertainties that may affect Lucid's future operations, see Part I, Item 1A, 'Risk Factors,' in Lucid's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, as the same may be updated in Part II, Item 1A, 'Risk Factors' in any Quarterly Report on Form 10-Q filed by Lucid Diagnostics after its most recent Annual Report. Lucid disclaims any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in its expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.
Malaysian Reserve
30-06-2025
- Malaysian Reserve
Susie White receives San Bernardino County Medical Society President's Award
RANCHO CUCAMONGA, Calif., June 30, 2025 /PRNewswire/ — Inland Empire Health Plan (IEHP) Chief Operating Officer Susie White received the San Bernardino County Medical Society's (SBCMS) 2025 President's Award during its annual Installation of Officers and Award Recognition Dinner in Victorville on June 26. The award is given to an individual who is committed to the organization's mission and purpose through health education, research and the protection of public health, among other contributing factors. 'This recognition is truly meaningful because it allows me to not only showcase my successes, but IEHP's as well,' said White. 'My story is just one of many, but its roots run deep and are 'watered' by a strong commitment to serve others through initiatives tailored to create lasting change in the Inland Empire.' Outgoing SBCMS President Dr. William Jih selected White for the award because of her transformative work in prioritizing a values-driven team culture and empowering health care professionals and patients. 'Susie White and her leadership at IEHP are the model of quality health care, and we are grateful for her dedication and pursuit of excellence,' said Jih. 'She has built a career from the ground up by constantly being someone that can be relied upon and trusted.' White began her tenure with IEHP in 1998, serving the organization in a variety of roles before being named to her current post in 2019. As the health plan's chief operating officer, White is responsible for IEHP's day-to-day operations, implementing strategic initiatives and policies that better serve the organization's members, team members and provider network. White holds a Bachelor of Science degree in health care management and a Master of Business Administration in management and leadership from the University of La Verne. She is also a champion for breast cancer awareness through advocacy work in the community in memory of her mother, Jo. SBCMS recognizes individuals and organizations making significant contributions in the field of health care at its annual dinner. A full list of 2025 award winners can be found on the Society's website at Learn more about IEHP and its work in the region at About IEHP With a mission to heal and inspire the human spirit, Inland Empire Health Plan (IEHP) is one of the top 10 largest Medicaid health plans, the largest not-for-profit Medicare-Medicaid public health plan in the country, and for the fifth year in a row, certified as A Great Place To Work®. Founded in 1996, IEHP supports more than 1.5 million Riverside and San Bernardino County residents enrolled in Medicaid or IEHP DualChoice (those with both Medi-Cal and Medicare). As of 2024, IEHP also offers Covered California plans, further ensuring health care access for even more IE residents. Today, IEHP has a robust network of quality doctors throughout our two counties and nearly 4,000 team members who are fully committed to the vision: We will not rest until our communities enjoy optimal care and vibrant health. To learn more, go to
